|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2182-2189.
Prepublished online as a Blood First Edition Paper on June 27, 2006; DOI 10.1182/blood-2006-01-010249.
Previous Article | Next Article 
Submitted January 10, 2006
Accepted April 10, 2006
Two novel activating mutations in the Wiskott-Aldrich
Syndrome protein resulting in congenital neutropenia
Phil J Ancliff*, Michael P Blundell, Giles O Cory, Yolanda Calle, Austen Worth, Helena Kempski, Siobhan Burns, Gareth E Jones, Jo Sinclair, Christine Kinnon, Ian M Hann, Rosemary E Gale, David C Linch, and Adrian J Thrasher
Department of Haematology, Great Ormond Street Hospital, London, UK
Molecular Immunology Unit, Institute of Child Health, University College London, UK
Department of Biochemistry, School of Medical Sciences, University of Bristol, UK
The Randall Centre for Molecular Mechanisms of Cell Function, King's College London, UK
Molecular Haematology Unit, Institute of Child Health, University College London, UK
The Randall Centre for Molecular
Royal Free and University College Medical School
* Corresponding author; email: anclip{at}gosh.nhs.uk.
Severe congenital neutropenia (SCN) is characterized by
neutropenia, recurrent bacterial infections and
maturation arrest in the bone marrow. Although many
cases have mutations in the ELA2 gene encoding
neutrophil elastase, a significant proportion remain
undefined at a molecular level. A mutation (L270P) in
the gene encoding the Wiskott-Aldrich Syndrome protein
(WASp) resulting in an X-linked SCN kindred has been
reported. We therefore screened the WAS gene in 14 young
SCN males with wild-type ELA2 and identified two with
novel mutations, one who presented with myelodysplasia
(I294T) and the other with classical SCN (S272P). Both
patients had defects of immunological function including
a generalized reduction of lymphoid and natural killer
cell numbers, reduced lymphocyte proliferation and
abrogated phagocyte activity. In vitro culture of bone
marrow progenitors demonstrated a profound reduction in
neutrophil production and increased levels of apoptosis,
consistent with an intrinsic disturbance of normal
myeloid differentiation as the cause of the
neutropenia. Both mutations resulted in increased WASp
activity and produced marked abnormalities of
cytoskeletal structure and dynamics. Furthermore, these
results also suggest a novel cause of myelodysplasia and
suggest that male children with myelodysplasia and
disturbance of immunological function should be screened
for such mutations.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Park and D. Cox
Cdc42 Regulates Fc{gamma} Receptor-mediated Phagocytosis through the Activation and Phosphorylation of Wiskott-Aldrich Syndrome Protein (WASP) and Neural-WASP
Mol. Biol. Cell,
November 1, 2009;
20(21):
4500 - 4508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Klein
Molecular basis of congenital neutropenia
Haematologica,
October 1, 2009;
94(10):
1333 - 1336.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Beel and P. Vandenberghe
G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia
Haematologica,
October 1, 2009;
94(10):
1449 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Blundell, G. Bouma, J. Metelo, A. Worth, Y. Calle, L. A. Cowell, L. S. Westerberg, D. A. Moulding, S. Mirando, C. Kinnon, et al.
Phosphorylation of WASp is a key regulator of activity and stability in vivo
PNAS,
September 15, 2009;
106(37):
15738 - 15743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Salipante, M. E. B. Rojas, B. Korkmaz, Z. Duan, J. Wechsler, K. F. Benson, R. E. Person, H. L. Grimes, and M. S. Horwitz
Contributions to Neutropenia from PFAAP5 (N4BP2L2), a Novel Protein Mediating Transcriptional Repressor Cooperation between Gfi1 and Neutrophil Elastase
Mol. Cell. Biol.,
August 15, 2009;
29(16):
4394 - 4405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bosticardo, F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome
Blood,
June 18, 2009;
113(25):
6288 - 6295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Velu, A. M. Baktula, and H. L. Grimes
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis
Blood,
May 7, 2009;
113(19):
4720 - 4728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Notarangelo and R. Badolato
Leukocyte trafficking in primary immunodeficiencies
J. Leukoc. Biol.,
March 1, 2009;
85(3):
335 - 343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Boztug, G. Appaswamy, A. Ashikov, A. A. Schaffer, U. Salzer, J. Diestelhorst, M. Germeshausen, G. Brandes, J. Lee-Gossler, F. Noyan, et al.
A Syndrome with Congenital Neutropenia and Mutations in G6PC3
N. Engl. J. Med.,
January 1, 2009;
360(1):
32 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Montoya-Durango, C. S. Velu, A. Kazanjian, M. E. B. Rojas, C. M. Jay, G. D. Longmore, and H. L. Grimes
Ajuba Functions as a Histone Deacetylase-dependent Co-repressor for Autoregulation of the Growth Factor-independent-1 Transcription Factor
J. Biol. Chem.,
November 14, 2008;
283(46):
32056 - 32065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G P Spickett
Immune deficiency disorders involving neutrophils
J. Clin. Pathol.,
September 1, 2008;
61(9):
1001 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Berliner
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
Blood,
June 15, 2008;
111(12):
5427 - 5432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Moulding, M. P. Blundell, D. G. Spiller, M. R.H. White, G. O. Cory, Y. Calle, H. Kempski, J. Sinclair, P. J. Ancliff, C. Kinnon, et al.
Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia
J. Exp. Med.,
September 3, 2007;
204(9):
2213 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Horwitz, Z. Duan, B. Korkmaz, H.-H. Lee, M. E. Mealiffe, and S. J. Salipante
Neutrophil elastase in cyclic and severe congenital neutropenia
Blood,
March 1, 2007;
109(5):
1817 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|